Skip to content

Single comment threadYou are looking at one branch of why is nobody talking about the SURPASS-CVOT readout — 37 comments in the full submission. View in context.

1.7k

c/tirzepatide·submitted 7 days ago by u/emil_okwuosa

why is nobody talking about the SURPASS-CVOT readout

Labbranch of 5 comments

Right, the SURPASS question again, but with numbers this time. I have 22 data points over 36 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 37 comments →

This branch

5 comments, started 5 days ago

u/incretin_ivyMOD81 points·5 days ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink

u/dexa_twice_yearlybody comp40 points·4 days ago

the GIP side does different things than the GLP-1 side, that is the point

replysharereportpermalink

load more comments (3) →

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers

130submissions

Aug 2023created

submissions / month, last year

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com

More in c/tirzepatide

1GIP: the version I wish someone had shown me in week 115k points · 13 comments
2[Lab] split one vial across VendorInvestigate and PeptideMeter — 98.0% and 99.0%13k points · 39 comments
3anyone else notice SURMOUNT kicking in around week 8012k points · 63 comments
4am I the only one who found GIP harder than the injections11k points · 47 comments
5nobody warned me about injection-site soreness and I would have liked the warning11k points · 47 comments
6am I the only one who found Mounjaro harder than the injections10k points · 47 comments

c/tirzepatide rules

"Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
Vial-splitting and self-compounding discussion stays in c/reconstitution.
No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
Independent community. Nobody here sells anything, and anyone who tries is banned.
Not medical advice. Describe what you did; never prescribe to a stranger.
Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
No contact handles, wallet addresses or tracking numbers — they identify people.
Be recognisably decent. Disagree hard, insult nobody.

Full rules and how they are enforced →

Moderators

u/titration_marshal u/incretin_ivy u/quiet_moderator u/dexa_twice_yearly

Volunteers. Unpaid, unaffiliated, and reachable through modmail only.

Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →